INSTI ® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
Conditions: Hepatitis C Interventions: Device: INSTI HCV Self Test Sponsors: bioLytical Laboratories Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
The Treatment of PD-1 Antibody Combined With Peg-IFN α in NAs-suppressed CHB Patients
Conditions: Chronic Hepatitis B Interventions: Drug: Sintilimab; Drug: Peg-IFN α-2b; Drug: NAs Sponsors: Beijing 302 Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function
Conditions: Alcoholic Hepatitis Interventions: Biological: Plasma Exchange; Other: Standard Medical Treatment Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Re-link HCV in Substance-Use Telemedicine Program
Conditions: Hepatitis C Interventions: Behavioral: Re-Link Sponsors: trueNorth Medical Centres; Gilead Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.
Conditions: Occult Hepatitis B in Cancer Patients Interventions: Other: Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs
Conditions: Hepatocellular Carcinoma Interventions: Diagnostic Test: General Evaluation Score (GES) Sponsors: Egyptian Liver Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
Conditions: Chronic Hepatitis b Interventions: Drug: Peginterferon α-2b based treatment group; Drug: NAs monotherapy group Sponsors: Qing XIe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses
Conditions: Hepatitis B; Hepatitis C Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Conditions: Chronic Hepatitis B Interventions: Drug: LW231 tablets; Drug: Placebo Sponsors: Shanghai Longwood Biopharmaceuticals Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers.
Conditions: Pain; Pediatrics; Vaccination; Virtual Reality Interventions: Device: Pico G2 Virtual Reality Glasses (Pico Interactive Inc), together with an Android AOYODKG tablet; Behavioral: Traditional Distractors; Biological: Triple Viral + Varicella Vaccine at 3 years of age; Biological: Hepatitis A + Diphtheria-Tetanus-Pertussis Vaccine at 6 years of age. Sponsors: Fundacio d ' Investigacio en Atencio Primaria Jordi Gol i Gurina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Retrospective Observational Study on the Effects of Prebiotics on HBsAg Clearance
Conditions: Chronic Hepatitis B Interventions: Drug: PegIFN α2b; Drug: PegIFNα2b+prebiotics; Drug: Nucleoside analog; Drug: Nucleoside analog+prebiotics Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
MRG-001 in Patients With Alcoholic Hepatitis
Conditions: Alcoholic Hepatitis; Acute Alcoholic Hepatitis Interventions: Drug: MRG-001 Sponsors: MedRegen LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
Conditions: HBV; Kidney Transplantation; Liver Transplantation Interventions: Drug: Tacrolimus; Drug: Belatacept Sponsors: University Hospital, Grenoble; National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Intra-Hepatic Microbiota in Alcoholic Hepatitis
Conditions: Cirrhosis; Alcoholic Liver Disease; Alcoholic Hepatitis Interventions: Procedure: Biological sampling Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Immunogenicity and Safety of Hecolin ® in HIV Positive/Negative Adults and in Children
Conditions: Hepatitis E Virus Infection Interventions: Biological: Hecolin ® Recombinant Hepatitis E Vaccine; Biological: Isotonic Sodium Chloride injection Sponsors: International Vaccine Institute; Xiamen Innovax Biotech Co., Ltd; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
